Papers

Peer-reviewed

Jun, 2011

Good Clinical Response to Erlotinib in a Patient With Anaplastic Thyroid Carcinoma Harboring an Epidermal Growth Factor Somatic Mutation, L858R, in Exon 21

JOURNAL OF CLINICAL ONCOLOGY

Katsuhiro Masago
Masako Miura
Yoshiro Toyama
Yosuke Togashi
Michiaki Mishima

Volume: 29
Number: 16
First page: E465
Last page: E467
Language: English
Publishing type: Research paper (scientific journal)
DOI: 10.1200/JCO.2010.34.0216
Publisher: AMER SOC CLINICAL ONCOLOGY

Link information

DOI: https://doi.org/10.1200/JCO.2010.34.0216
PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21422425
Web of Science: https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000291032200003&DestApp=WOS_CPL

ID information

DOI : 10.1200/JCO.2010.34.0216
ISSN : 0732-183X
Pubmed ID : 21422425
Web of Science ID : WOS:000291032200003

Export: BibTeX RIS